Jump to content

WHO warns of imminent spread of untreatable superbug gonorrhoea


humble3d

Recommended Posts

WHO warns of imminent spread of untreatable superbug gonorrhoea

 

Stay in your OWN knickers...

 

At least three people worldwide are infected with totally untreatable

"superbug" strains of gonorrhoea which they are likely to be spreading to

others through sex, the World Health Organization (WHO) said on Friday.


Giving details of studies showing a "very serious situation" with regard to

highly drug-resistant forms of the sexually-transmitted disease (STD), WHO

experts said it was "only a matter of time" before last-resort gonorrhoea

antibiotics would be of no use.


"Gonorrhoea is a very smart bug," said Teodora Wi, a human reproduction

specialist at the Geneva-based U.N. health agency.


"Every time you introduce a new type of antibiotic to treat it, this bug

develops resistance to it."


The WHO estimates 78 million people a year get gonorrhoea, an STD that can

infect the genitals, rectum and throat.


The infection, which in many cases has no symptoms on its own, can lead to

pelvic inflammatory disease, ectopic pregnancy and infertility, as well as

increasing the risk of getting HIV.


Wi, who gave details in a telephone briefing of two studies on gonorrhoea

published in the journal PLOS Medicine, said one had documented three

specific cases - one each in Japan, France and Spain - of patients with

strains of gonorrhoea against which no known antibiotic is effective.


"These are cases that can infect others.


It can be transmitted," she told reporters. "And these cases may just be the

tip of the iceberg, since systems to diagnose and report untreatable

infections are lacking in lower-income countries where gonorrhoea is

actually more common."


DRUG RESISTANCE


The WHO's programme for monitoring trends in drug-resistant gonorrhoea found

in a study that from 2009 to 2014 there was widespread resistance to the

first-line medicine ciprofloxacin, increasing resistance to another

antibiotic drugs called azithromycin, and the emergence of resistance to

last-resort treatments known as extended-spectrum cephalosporins (ESCs).


In most countries, it said, ESCs are now the only single antibiotics that

remain effective for treating gonorrhoea.


Yet resistance to them has already been reported in 50 countries.


Manica Balasegaram, director of the Global Antibiotic Research and

Development Partnership, said the situation was "grim" and there was a

"pressing need" for new medicines.


The pipeline, however, is very thin, with only three potential new

gonorrhoea drugs in development and no guarantee any will prove effective in

final-stage trials, he said.


"We urgently need to seize the opportunities we have with existing drugs and

candidates in the pipeline," he told reporters.


"Any new treatment developed should be accessible to everyone who needs it,

while ensuring it is used appropriately, so that drug resistance is slowed

as much as possible."

 

http://news.trust.org/item/20170706230350-0v27u


RELATED:


Research raises hopes for gonorrhea vaccine

http://www.cnn.com/2017/07/10/health/gonorrhea-vaccine-study/index.html

 

Link to comment
Share on other sites


  • Replies 3
  • Views 657
  • Created
  • Last Reply

Archived

This topic is now archived and is closed to further replies.

  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...